Satter Management Co., L.P. Annexon, Inc. Transaction History
Satter Management Co., L.P.
- $52.8 Million
- Q4 2024
A detailed history of Satter Management Co., L.P. transactions in Annexon, Inc. stock. As of the latest transaction made, Satter Management Co., L.P. holds 7,406,024 shares of ANNX stock, worth $20.2 Million. This represents 71.99% of its overall portfolio holdings.
Number of Shares
7,406,024
Previous 7,406,024
-0.0%
Holding current value
$20.2 Million
Previous $43.8 Million
13.35%
% of portfolio
71.99%
Previous 76.44%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
96.8MCall Options Held
36.9KPut Options Held
83K-
Bvf Inc San Francisco, CA7MShares$19.1 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.2 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.38MShares$14.7 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA5.25MShares$14.3 Million3.4% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $130M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...